The Advantages of New Multimodality Imaging in Choosing the Optimal Management Strategy for Patients with Hypertrophic Cardiomyopathy
Open Access
- 18 September 2020
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 10 (9), 719
- https://doi.org/10.3390/diagnostics10090719
Abstract
In recent years, significant advances have been made in the diagnosis and therapeutic management of hypertrophic cardiomyopathy (HCM) patients, which has led to an important improvement in their longevity and quality of life. The use of multimodality imaging has an essential role in the diagnosis, assessing the regional distribution and severity of the disease, with important prognostic implications. At the same time, imaging contributes to the identification of optimal treatment for patients with hypertrophic cardiomyopathy, whether it is pharmaceutical, interventional or surgical treatment. Novel pharmacotherapies (like myosin inhibitors), minimally invasive procedures (such as transcatheter mitral valve repair, high-intensity focused ultrasound or radiofrequency ablation) and gene-directed approaches, may soon become alternatives for HCM patients. However, there are only few data on the early diagnosis of patients with HCM, in order to initiate treatment as soon as possible, to reduce the risk of sudden cardiac death (SCD). The aim of our review is to highlight the advantages of contemporary imaging in choosing the optimal management strategies for HCM patients, considering the novel therapies which are currently applied or studied for these patients.Keywords
This publication has 89 references indexed in Scilit:
- Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic reviewHeart, 2013
- Identification and Assessment of Anderson-Fabry Disease by Cardiovascular Magnetic Resonance Noncontrast Myocardial T1 MappingCirculation: Cardiovascular Imaging, 2013
- Risk of Death in Long-Term Follow-Up of Patients With Apical Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2013
- Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic CardiomyopathyJACC: Cardiovascular Imaging, 2012
- Late gadolinium enhancement on cardiac magnetic resonance and phenotypic expression in hypertrophic cardiomyopathyAmerican Heart Journal, 2011
- Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2009
- Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathyEuropean Heart Journal, 2009
- Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: A 12-month follow-up studyAmerican Heart Journal, 2009
- The Effects of Candesartan on Left Ventricular Hypertrophy and Function in Nonobstructive Hypertrophic Cardiomyopathy: A Pilot, Randomized StudyThe Journal of Molecular Diagnostics, 2009
- Idiopathic Hypertrophic Subaortic Stenosis: I. A Description of the Disease Based Upon an Analysis of 64 PatientsCirculation, 1964